BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
1327 results:

  • 1. Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.
    Rogges E; Pelliccia S; Savio C; Lopez G; Della Starza I; La Verde G; Di Napoli A
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612584
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
    Kulczycka M; Derlatka K; Tasior J; Sygacz M; Lejman M; Zawitkowska J
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612531
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
    Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
    Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
    [No Abstract]    [Full Text] [Related]  

  • 6. High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study.
    Chen X; Li J; Yu L; Hu W; Cai J; Wang Z; Chen C; Zhang X; Xie Y; Wu K; Mo Y; Chen J; Shen S
    Br J Haematol; 2024 Apr; 204(4):1354-1366. PubMed ID: 38432257
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells.
    Kreissig S; Windisch R; Wichmann C
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201282
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lineage switch of kmt2a-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy.
    Wu JR; Shih PC; Li C; Chao HL; Wang HC; Chiang YM; Liu YJ; Hsu SC; Yao CY; Chen LH; Lin CC; Tien HF; Chou WC
    J Hematop; 2023 Jun; 16(2):103-109. PubMed ID: 38175441
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Two cases of mycosis fungoides with large cell transformation with kmt2a rearrangements.
    Wadsworth PA; Lawrence L; Suarez CJ; Saleem A; Khodadoust MS; Kim YH; Rieger KE; Fernandez-Pol S
    J Hematop; 2023 Dec; 16(4):227-234. PubMed ID: 38175436
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia].
    Shi Y; Lu Y; Zhang RD; Zhang YY; Lin W; Yu JJ; Wu Y; Fan J; Qi PJ; Huang PL; Cai LX; Huang Q; Zhang P; Sun YM; Liu Y; Zheng HY
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):49-54. PubMed ID: 38154977
    [No Abstract]    [Full Text] [Related]  

  • 12. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Increased Incidence of TdT-negative Pre-B Acute Lymphoblastic Leukemia Associated With Poor Prognostic Features Among Mexican Children in Central Mexico.
    Vacek M; Zárraga Vargas LC; González Domínguez E; Garcia Rodriguez L; Tello Teran OA; Mojica Cardoso C; Ocampo Roosens LV; Acevedo Fernandez JJ; Li W; Lee B; Olalla Tapia JS; Flatt T
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e131-e136. PubMed ID: 38132672
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Raman classification of selected subtypes of acute lymphoblastic leukemia (ALL).
    Adamczyk A; Nowakowska AM; Jakubowska J; Zabczynska M; Bartoszek M; Kashyrskaya S; Fatla A; Stawoski K; Siakala K; Pastorczak A; Ostrowska K; Mlynarski W; Majzner K; Baranska M
    Analyst; 2024 Jan; 149(2):571-581. PubMed ID: 38099606
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
    Conter V; Valsecchi MG; Cario G; Zimmermann M; Attarbaschi A; Stary J; Niggli F; Dalla Pozza L; Elitzur S; Silvestri D; Locatelli F; Möricke A; Engstler G; Smisek P; Bodmer N; Barbaric D; Izraeli S; Rizzari C; Boos J; Buldini B; Zucchetti M; von Stackelberg A; Matteo C; Lehrnbecher T; Lanvers-Kaminsky C; Cazzaniga G; Gruhn B; Biondi A; Schrappe M
    J Clin Oncol; 2024 Mar; 42(8):915-926. PubMed ID: 38096462
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Clinical Analysis of Infants with Acute Lymphoblastic Leukemia (18 cases)].
    Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia in young adults: which treatment?
    Anandappa A; Curran E
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):587-592. PubMed ID: 38066918
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
    Gutierrez-Camino A; Richer C; Ouimet M; Fuchs C; Langlois S; Khater F; Caron M; Beaulieu P; St-Onge P; Bataille AR; Sinnett D
    Br J Cancer; 2024 Feb; 130(2):317-326. PubMed ID: 38049555
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinical analysis of long-term survival and influencing factors of chimeric antigen receptor T-cell therapy in relapsed/refractory acute B-cell lymphoblastic leukemia].
    Wang Y; Gao QY; Wang H; Zhang D; Gao Y; Miao YD; Zhai XH; Hu XX; Rui XL; Zhang WH
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):800-804. PubMed ID: 38049330
    [No Abstract]    [Full Text] [Related]  

  • 20. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with kmt2a::AFF1 fusion.
    Tretti Parenzan C; Molin AD; Longo G; Gaffo E; Buratin A; Cani A; Boldrin E; Serafin V; Guglielmelli P; Vannucchi AM; Cazzaniga G; Biondi A; Locatelli F; Meyer LH; Buldini B; Te Kronnie G; Bresolin S; Bortoluzzi S
    Blood Adv; 2024 Mar; 8(5):1305-1319. PubMed ID: 38029383
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 67.